GEMCX
Price
$23.95
Change
-$0.01 (-0.04%)
Updated
Nov 19 closing price
Net Assets
2.9B
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

GEMCX vs VEIEX

Header iconGEMCX vs VEIEX Comparison
Open Charts GEMCX vs VEIEXBanner chart's image
Goldman Sachs Emerging Markets Eq C
Price$23.95
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets2.9B
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
GEMCX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
GEMCX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEMCX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. GEMCX (2.9B). VEIEX pays higher dividends than GEMCX: VEIEX (2.61) vs GEMCX (0.00). GEMCX was incepted earlier than VEIEX: GEMCX (28 years) vs VEIEX (32 years). GEMCX (2.24) is less costly to investors than VEIEX (0.29). GEMCX is a more actively managed with annual turnover of: 36.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than GEMCX: VEIEX (0) vs GEMCX (1000). GEMCX annual gain was more profitable for investors over the last year : 23.89 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. GEMCX (4.02).
GEMCXVEIEXGEMCX / VEIEX
Total Expense Ratio2.090.29721%
Annual Report Gross Expense Ratio2.240.29772%
Fund Existence28 years32 years-
Gain YTD26.43822.205119%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRA250N/A-
Net Assets2.9B141B2%
Annual Yield % from dividends0.002.61-
Returns for 1 year23.8920.18118%
Returns for 3 years45.9447.2397%
Returns for 5 years4.0223.3817%
Returns for 10 years80.4678.61102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics